Tentative Program

This track will explore the latest developments in immunotherapy for infectious diseases, focusing on novel therapeutic strategies and their clinical applications. Discussions will include the mechanisms of action, efficacy, and safety profiles of emerging immunotherapeutic agents.

This session will delve into the intricate mechanisms of the immune response to infectious agents, highlighting both innate and adaptive immunity. Researchers will present findings on how immune cells interact with pathogens and the subsequent immune signaling pathways involved.

Focusing on cutting-edge vaccine research, this track will cover novel vaccine platforms, adjuvants, and delivery systems aimed at enhancing immune responses. Participants will discuss challenges in vaccine design and strategies for overcoming them in the context of infectious diseases.

This session will examine the dynamic interactions between pathogens and their hosts, emphasizing the strategies employed by pathogens to evade immune detection. Insights into the molecular mechanisms of these interactions will be shared, along with implications for disease control.

This track will investigate the role of cytokine signaling in modulating immune responses during infectious diseases. Presentations will focus on the balance of pro-inflammatory and anti-inflammatory cytokines and their impact on disease outcomes.

This session will explore the immunopathogenic mechanisms underlying various infectious diseases, including the role of immune dysregulation in disease progression. Researchers will present case studies illustrating the impact of immune responses on disease severity.